Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI).
Joseph A, Moriceau S, Sica V, Anagnostopoulos G, Pol J, Martins I, Lafarge A, Maiuri MC, Leboyer M, Loftus J, Bellivier F, Belzeaux R, Berna F, Etain B, Capdevielle D, Courtet P, Dubertret C, Dubreucq J, Thierry A, Fond G, Gard S, Llorca PM, Mallet J, Misdrahi D, Olié E, Passerieux C, Polosan M, Roux P, Samalin L, Schürhoff F, Schwan R; FACE-SZ and FACE-BD (FondaMental Academic Centers of Expertise, for Schizophrenia and for Bipolar Disorder) Groups; Magnan C, Oury F, Bravo-San Pedro JM, Kroemer G.
Joseph A, et al. Among authors: anagnostopoulos g.
Cell Death Dis. 2020 Jul 6;11(7):502. doi: 10.1038/s41419-020-2716-5.
Cell Death Dis. 2020.
PMID: 32632162
Free PMC article.